CD86 and gastric adenocarcinoma: More specifically, in STAD, marker sets of monocytes (CD86, CSF1R), TAMs (CCL-2, IL10), and M2 macrophages (MS4A4A, CD163 and VSIG4) have significant correlation with C3 expression.